文献速递妇科

低级别卵巢癌患者的生活质量与生存体验

Quality of life and survivorship in patients with low-grade ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2024-08-21

研究比较低级别(LGOC,N=85)与高级别(HGOC,N=578)卵巢癌患者基线心理社会因素、唾液皮质醇、血白细胞介素-6(IL-6)及术中肿瘤皮质醇的差异,并随访诊断后1年的变化。LGOC患者基线抑郁和睡眠障碍较少,但抑郁情绪与生活质量无显著差异;1年后两组合并分析显示生活质量与疲劳改善、植物神经性抑郁与IL-6下降。

要点

  • LGOC患者基线抑郁(p=0.018)和睡眠障碍(p=0.014)较HGOC少,抑郁情绪与生活质量无显著差异。
  • LGOC肿瘤皮质醇较HGOC有降低趋势(p=0.078)。
  • 诊断后1年生活质量与疲劳改善、植物神经性抑郁与IL-6下降,与级别无关。

核心结论

  • 尽管LGOC预后更好,LGOC患者出现情绪障碍的可能性与HGOC患者相当。
  • 肿瘤皮质醇水平按级别存在差异的趋势。
  • 研究结果强调需关注低级别和高级别卵巢恶性肿瘤患者的健康状态。

研究设计与样本

  • 研究纳入HGOC患者578例和LGOC患者85例。
  • 参与者在初次手术或新辅助化疗前完成心理社会因素基线评估,并提供唾液测皮质醇、血液测IL-6。
  • 术中采集样本测肿瘤皮质醇。
  • 采用一般线性模型检验生物学与心理学变量按级别的差异。

主要发现

  • 调整年龄和疾病分期后,LGOC患者基线报告的抑郁(p=0.018)和睡眠障碍(p=0.014)少于HGOC患者,抑郁情绪(p=0.11)与生活质量(p=0.51)无显著差异。
  • LGOC相比HGOC肿瘤皮质醇水平有降低趋势(p=0.078)。
  • 诊断后1年,无论级别,生活质量和疲劳显著改善,植物神经性抑郁和IL-6水平下降。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High-grade (HGOC) and low-grade ovarian carcinoma (LGOC) are distinct malignancies with different biological features, treatment paradigms, and life expectancies. However, differences in quality of life (QOL), sleep, and depressive symptoms have not been examined by grade, and neither have inflammatory profiles associated with these symptoms. We aim to characterize QOL and biomarkers by OC grade. METHODS: Participants included patients with HGOC (N = 578) or LGOC (N = 85). Participants completed baseline assessments of psychosocial factors prior to primary surgery or neoadjuvant chemotherapy and contributed saliva for cortisol and blood for interleukin-6 (IL-6) quantification. Samples were collected intraoperatively to quantify tumor cortisol. General linear models were used to examine differences in biological and psychological variables by grade. RESULTS: At baseline, patients with LGOC reported less depression (p = 0.018) and sleep disturbances (p = 0.014), but no significant difference in depressive mood (p = 0.11) or QOL (p = 0.51) compared to patients with HGOC, adjusting for age and disease stage. There were trends towards lower tumor cortisol levels (p = 0.078) in LGOC compared to HGOC. One-year post-diagnosis, we found a significant improvement in QOL and fatigue, and a decrease in vegetative depression and IL-6 levels irrespective of grade. CONCLUSIONS: We present the first characterization of psychosocial experiences of patients with LGOC. Despite having a better disease prognosis, patients with LGOC were just as likely to have mood disturbances as those with HGOC. There was a trend towards differences in tumor cortisol by grade. Our findings highlight the need to address well-being in patients with both low- and high-grade ovarian malignancies.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lemieux M, Telles R, Goodheart M, et al. Quality of life and survivorship in patients with low-grade ovarian cancer. Gynecol Oncol. 2024. PMID: 39173565. doi:10.1016/j.ygyno.2024.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。